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Nowadays probably every person came across the term 
Psychotherapy. It seems, however, not 
to be so clear what psychotherapy 
actually means. Besides that, it 
seems to be not so clear, what a 
Psychotherapist does and how s/he 
can assist someone, who finds himself 
temporarily in distress. When we speak 
about psychotherapy, we refer to a form 
of therapeutic interaction or intervention 
which usually addresses emotional 
issues. 
Accredited psychotherapists 
are highly trained people, who have 
undergone strictly regulated schooling 
in one or more of the officially 
recognized forms of psychotherapy. 
This training takes up to four years 
and even more. During their training 
course psychotherapists have to 
undergo their own personal therapeutic 
journey. Following accreditation, a 
psychotherapist is asked to take 
part in supervision groups, personal 
development groups and to attend 
seminars and workshops to further 
his knowledge and education. The 
therapist’s on-going personal and 
professional journey will equip him 
for his métier with the right amount of 
empathy and experience to choose 
from the best instruments available the 
most appropriate one to work with the 
individual patient’s issues. 
Persons can avail themselves of 
the support of a psychotherapist as 
individual patients, groups, couples, 
or families. The session’s focus will 
address the person’s or the group’s 
environment, since human beings do 
not live isolated from one another. 
Fundamentally we all are historically 
- somewhat coarsely expressed – 
gregarious animals.
The journey of discovering the 
roots of the difficulties experienced 
throughout a momentary phase of life 
might bring into awareness issues with 
every day contacts like the partner, 
members of the patient’s close family, 
work, school, or any other social group. 
Confidentiality in psychotherapeutic 
sessions is of critical importance and 
stipulated in the regulatory statutes of 
the psychotherapeutic organization’s 
code of ethics. A psychotherapist who 
does not respect those statutes is in 
danger of losing his credibility, and also 
his right to practice in his profession. A 
trained professional would unlikely want 
to risk that. 
When it comes to the topics that 
can be dealt with in psychotherapy 
there is hardly anything that cannot be 
addressed. Psychotherapists however, 
might have specialized themselves in a 
particular field. In such a case, a patient 
can be referred to a colleague with the 
respective specialized background. 
Psychotherapy can improve the 
response to prescribed medication 
and help the patient to recover quicker. 
Vice-versa the psychotherapist might 
decide that it would be of advantage for 
the patient to see a medical practitioner 
to evaluate the possibility of introducing 
medication. The psychotherapist and 
the medical practitioner can thus 
decide together on the management 
of the patient by monitoring the 
improvement of the patient’s emotional 
rebalancing.
Psychotherapy aims to help patients 
to cope better with their lives and 
the challenges, learn about conflict 
management and self-growth, and to 
reach their full potential. Within the 
therapeutic setting, the psychotherapist 
creates an environment that is 
potentially healing for the patient. 
Mental and emotional health and fitness 
are efficient allies when it comes to 
seriously tackling all sorts of crisis. 
Therefore, the psychotherapist’s 
aspiration will be that of strengthening 
both, be it as prevention for future 
hardships, or as cure for a momentary 
deadlock in a difficult life-situation. 
 During eachsession the 
psychotherapist strives to increase 
awareness, insight and understanding. 
To reach this goal the therapist will 
use different techniques.  Amongst 
others the therapist will aim to support 
the patient to recognize his behaviour 
or thinking patterns that once might 
have been useful but now sabotages 
the patient’s well-being. Through 
broader awareness the patient can 
ultimately expand his capacity for self-
observation, become more aware to 
undesired behaviour, develop insight 
and empathy. 
Be it with medication or without, 
through the interventions given by the 
psychotherapist, the patient will with 
time be able to change his thoughts 
and feelings and as a result change his 
patterns and his behaviour. Through 
this changed behaviour the patient will 
increase his sense of well-being. 
Coming to the end of this 
therapeutic journey, the patient will be 
able to cope better with discomfort and 
distress, and his perception of reality 
will be balanced, so that he can clearly 
see the variety of his choices - and 
choose freely.  
FOCUS ON
Mental and Emotional Health
Psychotherapy aims to help patients to cope 
better with their lives and the challenges, 
learn about conflict management and 







•  Contains amoxicillin and clavulanic acid in 2 ratios 4:1 
and 7:1, the powerful combination to fi ght infections in 
unique Solutab® formulation.
•  Indicated for the treatment of infections caused by Gram-
negative and Gram-positive bacteria, resistant to amoxi-
cillin as a consequence of ß-lactamase, however sensitive 
to amoxicillin and clavulanic acid used as a combination.
•  Usual daily dosage:
 - Adults and children over 40 kg (12 years)
  - Forcid Solutab 500/125 tablet 3 times a day or
  - Forcid Solutab 875/125 tablet 2 times a day
 - For mild to moderate infections
  - Forcid Solutab 500/125 tablet 2 times a day
•  Suitable for treatment of the following patients:
 -  patients with upper respiratory tract infections
 -  patients with lower respiratory tract infections, in 
particular severe exacerbations of chronic bronchitis; 
community acquired pneumonia
 -  patients with renal infections and lower genitourinary 
tract infections, except prostatitis
 -  patients with infections of the skin and soft tissue
Solutab® provides 
rapid absorption and 
high bio availability 
of both amoxicillin 
alone and amoxicillin 
with clavulanic acid.
Solutab® is versatile 
in its administration: 
it can be swallowed 
intact or dispersed 
in water.
Abbreviated Prescription Information
Presentations: Forcid Solutab® 500/125, Forcid Solutab® 875/125, containing as active substances amoxicillin and clavulanic acid. Each tablet/dispersible tablet contains 500 mg, 875 mg amoxicillin as amoxicillin trihydrate and 125 mg clavulanic acid as 
potassium clavulanate. Indications: Treatment of bacterial infections induced by Gram-negative and Gram-positive amoxicillin-resistant micro-organisms whose resistance is caused by beta-lactamases which however are sensitive to the combination of amoxicillin 
and clavulanic acid. Forcid Solutab is suitable for treatment of the following indications: • Upper and lower respiratory tract infections (acute otitis media; acute sinusitis; acute exacerbations of chronic bronchitis; pneumonia obtained outside a hospital) • kidneys 
and lower urogenital tract • skin and soft tissue. Duration of administration: As a rule Forcid is administered for a further 3 or 4 days after improvement of the clinical symptoms. Therapy over at least 10 days is indicated in the treatment of infections with 
beta-haemolytic streptococci in order to prevent late complications (e.g. rheumatic fever, glomerulonephritis). However, Forcid Solutab should not be used for more than 14 days without assessing the liver function of the patient. Adults and children over 40 kg 
body weight: The usual posology of 500/125 mg is 3 times a day (every 8 hours). For severe, chronical and relapsing infections, this dosage may be doubled. The usual posology of 875/125 mg is 2 times a day. The single dose should be taken at regular intervals 
throughout the day; ideally at 12 hours interval. Elderly patients: Posology as for adults. Patients with impaired renal function: In patients with renal insuffi ciency the excretion of clavulanate and amoxicillin through the kidneys is delayed. Forcid Solutab 875/125 
tablets may only be given to patients with a glomerular fi ltration rate > 30 ml/min. No dose adjustment is required then. Patients with impaired liver function: The combination amoxicillin/clavulanate should be administered cautiously to patients with liver 
impairment. The liver function should be monitored at regular intervals. There are, as yet, insuffi cient data on which to base a dosage recommendation. Method of administration: To prevent possible gastro-intestinal undesirable effects, Forcid Solutab should 
be taken at the start of the meal. Forcid Solutab tablets can be swallowed whole with a glass of water, or fi rst dissolved in a 1/2 cup of water (at least 30 ml) and stirred thoroughly before swallowing. Contraindications: Hypersensitivity to amoxicillin, clavulanic 
acid or to any of the excipients. Hypersensitivity to any other ß-lactam antibiotic like penicillins and cephalosporins. A previous history of amoxicillin/clavulanate associated jaundice or hepatic dysfunction. Patients with infectious mononucleosis (glandular fever) and 
patients with lymphatic leukaemia have a higher risk of exanthema and consequently amoxicillin/clavulanate must not be administered in these diseases for concomitantly occurring bacterial infections. Special warnings and precautions for use: Serious and 
occasionally fatal cases of hypersensitivity (anaphylactic reactions) have been reported for patients on penicillin treatment. These reactions are more common for patients with a history of hypersensitivity. Treatment with Forcid Solutab must be stopped immediately 
and replaced by another suitable therapy. Suitable therapy to treat symptoms of an anaphylactic reaction may be necessary, such as immediate administration of epinephrine, intravenous steroids and the treatment of respiratory insuffi ciency. Forcid Solutab should be 
used with caution in patients with known severe allergies or asthma since such patients are more likely to respond with allergic reactions. Cross-hypersensitivity and cross-resistance between the penicillins and cephalosporins can exist. As is the case for other broad 
spectrum antibiotics, superinfections may occur, particularly in patients with chronic diseases and/or dysfunctioning immune responses. Mucocutane candida infections have been observed. If superinfections occur, the medicinal product should be discontinued and/
or an appropriate therapy should be initiated. Patients with severe gastrointestinal disturbances with vomiting and/or diarrhoea should not be treated with Forcid Solutab since adequate absorption can not be guaranteed. In case of severe and persistent diarrhoea, 
the possibility of pseudomembraneous colitis must be considered and if not refuted, therapy should be discontinued and appropriate measures should be taken. The necessary measures should also be taken if haemorrhagic colitis occurs. The use of antiperistaltics is 
contraindicated in such cases. Administration of the amoxicillin/clavulanate combination to patients with a disturbed liver function should be approached with caution. Liver function should be monitored on a regular basis. Forcid Solutab 875/125 is not recommended 
for patients with a glomerular fi ltration rate ≤ 30 ml/min. In case of long-term treatment regular checks of renal and hepatic function and haematological studies are indicated. Amoxicillin/clavulanate should be used with care in patients on anti-coagulation therapy, 
since prolongation of the prothrombin time has been observed rarely. The presence of high urinary concentrations of amoxicillin can cause precipitation of amoxicillin in urinary catheters. Therefore, the catheter should be checked at regular interval in such cases. 
Forcid Solutab contains the following quantities of potassium per tablet: Forcid Solutab 500/125: 24.53 mg, Forcid Solutab 875/125: 25 mg. Pregnancy and lactation: Following administration of amoxicillin/clavulanic acid to pregnant women, no detrimental 
effects in the foetus or neonate could be observed. However, a single study in women with premature rupture of the amnion reported that prophylactic treatment with amoxicillin/clavlanic acid can be associated with an increased risk of necrotising enterocolitis in 
neonates. As a precautionary measure, Forcid Solutab should only be used during pregnancy after benefi t/risk assessment by the physician in charge. Forcid Solutab should be avoided during the fi rst trimester of pregnancy. Both substances reach the embryo/foetus 
via the placenta and are excreted in maternal milk. (Nothing is known about the effects of clavulanic acid on the breast-fed infant). Therefore, diarrhoea and fungus infections of the mucous membranes could occur in the breast-fed infant, so that nursing might have 
to be discontinued. The possibility of sensitising should be born in mind. Marketing authorization holder: Astellas Pharma International BV., Elisabethhof 19, 2353 EW Leiderdorp, The Netherlands. 12-FOR-004
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